Announcements

Performance Food Group Company filed a Form 8-K with the SEC on August 12, 2026, announcing the results of its operations for the fiscal quarter and fiscal year ended June 27, 2026, via a press release furnished as Exhibit 99.1.

Trimble Inc. filed a Form 8-K on August 12, 2026, disclosing its financial results for the quarter ended July 3, 2026, and announcing a new $1.0 billion share repurchase authorization approved by its Board of Directors on August 10, 2026.

Illumina, Inc. filed a Form 8-K on August 12, 2026, disclosing that on August 10, 2026, it entered into an Underwriting Agreement for the issuance and sale of $300,000,000 aggregate principal amount of 4.950% notes due 2029.

Brinker International, Inc. filed a Form 8-K on August 12, 2026, disclosing a new $718.0 million addition to its share repurchase authorization and the release of its fourth quarter fiscal 2026 earnings press release.

Definium Therapeutics, Inc. filed a Form 8-K with the SEC on August 12, 2026, disclosing positive topline data from its Phase 3 Voyage study of DT120 ODT for the treatment of generalized anxiety disorder.

Rimini Street, Inc. filed a Form 8-K on August 12, 2026, disclosing the appointment of Keith C. Costello, age 60, as Executive Vice President and Chief Operating Officer, effective August 17, 2026.

Madrigal Pharmaceuticals, Inc. filed a Form 8-K on August 12, 2026, reporting the election of John C. Reed, M.D., Ph.D. to its Board of Directors effective August 11, 2026, along with details of his compensation arrangements.